Publication | Closed Access

Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: Design, synthesis, QSAR analysis and anticancer activity

Medicinal ChemistryQsar AnalysisBiochemistryMedicineNatural SciencesHeterocycle ChemistryDrug DevelopmentPharmacologyPharmaceutical ChemistryCfm-1 AnalogsCertain Novel N-Drug Discovery